Polynovo Ltd - Asset Resilience Ratio
Polynovo Ltd (PNV) has an Asset Resilience Ratio of 0.04% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Polynovo Ltd (PNV) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2025)
This chart shows how Polynovo Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Polynovo Ltd.
Liquid Assets Composition Over Time
This chart breaks down Polynovo Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Polynovo Ltd (PNV) long-term investment share to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$50.00K | 0.04% |
| Total Liquid Assets | AU$50.00K | 0.04% |
Asset Resilience Insights
- Limited Liquidity: Polynovo Ltd maintains only 0.04% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Polynovo Ltd Industry Peers by Asset Resilience Ratio
Compare Polynovo Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Shandong Weigao Orthopaedic Device Co. Ltd. A
SHG:688161 |
Medical Devices | 6.28% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Ningbo David Medical Device Co Ltd
SHE:300314 |
Medical Devices | 5.11% |
|
Beijing Succeeder Technology Inc
SHG:688338 |
Medical Devices | 28.27% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 3.90% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
Annual Asset Resilience Ratio for Polynovo Ltd (2000–2025)
The table below shows the annual Asset Resilience Ratio data for Polynovo Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 5.46% | AU$6.96 Million ≈ $4.92 Million |
AU$127.41 Million ≈ $90.15 Million |
-16.88pp |
| 2024-06-30 | 22.34% | AU$24.29 Million ≈ $17.19 Million |
AU$108.72 Million ≈ $76.93 Million |
+22.29pp |
| 2023-06-30 | 0.05% | AU$50.00K ≈ $35.38K |
AU$92.62 Million ≈ $65.54 Million |
-0.09pp |
| 2022-06-30 | 0.14% | AU$50.00K ≈ $35.38K |
AU$34.97 Million ≈ $24.74 Million |
+0.01pp |
| 2021-06-30 | 0.13% | AU$50.00K ≈ $35.38K |
AU$38.34 Million ≈ $27.13 Million |
0.00pp |
| 2020-06-30 | 0.13% | AU$50.00K ≈ $35.38K |
AU$37.86 Million ≈ $26.79 Million |
-0.05pp |
| 2019-06-30 | 0.18% | AU$50.00K ≈ $35.38K |
AU$28.23 Million ≈ $19.97 Million |
-63.70pp |
| 2018-06-30 | 63.88% | AU$19.05 Million ≈ $13.48 Million |
AU$29.82 Million ≈ $21.10 Million |
+63.46pp |
| 2017-06-30 | 0.41% | AU$50.00K ≈ $35.38K |
AU$12.06 Million ≈ $8.53 Million |
+0.10pp |
| 2016-06-30 | 0.31% | AU$50.00K ≈ $35.38K |
AU$16.02 Million ≈ $11.34 Million |
-0.43pp |
| 2015-06-30 | 0.74% | AU$60.00K ≈ $42.45K |
AU$8.13 Million ≈ $5.75 Million |
+0.10pp |
| 2014-06-30 | 0.64% | AU$60.00K ≈ $42.45K |
AU$9.41 Million ≈ $6.66 Million |
-12.82pp |
| 2013-06-30 | 13.46% | AU$1.16 Million ≈ $820.77K |
AU$8.62 Million ≈ $6.10 Million |
-7.42pp |
| 2012-06-30 | 20.88% | AU$1.86 Million ≈ $1.32 Million |
AU$8.91 Million ≈ $6.30 Million |
-11.06pp |
| 2011-06-30 | 31.94% | AU$3.76 Million ≈ $2.66 Million |
AU$11.77 Million ≈ $8.33 Million |
+31.54pp |
| 2010-06-30 | 0.40% | AU$60.00K ≈ $42.45K |
AU$15.02 Million ≈ $10.63 Million |
-86.21pp |
| 2000-06-30 | 86.61% | AU$10.36 Million ≈ $7.33 Million |
AU$11.96 Million ≈ $8.46 Million |
-- |
About Polynovo Ltd
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for her… Read more